-
Uncategorized2 months ago
Targeted Gene Delivery Calms Lung Inflammation in Respiratory Infection Mouse Models
A group of scientists have developed a targeted delivery platform that can induce anti-inflammatory cytokine expression in mouse lungs, which helps restrict tissue damage from respiratory...
-
Uncategorized2 months agoSTAT+: A pancreatic cancer expert on why Revolution Medicines’ study could ‘open up a new era’ of treatment
Revolution Medicines announced a stunning survival benefit for its experimental drug in a Phase 3 pancreatic cancer study this week. Patients with advanced pancreatic adenocarcinoma who...
-
Uncategorized2 months ago
New CDC pick Schwartz is praised by public health pros
New CDC pick Schwartz is praised by public health pros
-
Uncategorized2 months agoFor What’s Next: Preparing Today’s Lab or Tomorrow’s Discoveries
Modern biology is accelerating at an unprecedented pace, and with it comes increasing complexity. As a result, researchers are shifting toward more patient reflective models, uncovering...
-
Uncategorized2 months agoThe State of Multiomics & NGS
REGISTER NOW Broadcast Date: Wednesday, April 29, 2026 Time: 08:00 PDT, 11:00 EDT, 15:00 GMT Next-generation sequencing (NGS) has never been cheaper or more accessible. In turn, spatial...
-
Uncategorized2 months ago
Kailera IPO interview: CEO Renaud talks biotech market, China and obesity pipeline
On Friday, Kailera Therapeutics raised a record-setting $625 million through an IPO on the Nasdaq. Founded with backing from Bain Capital Life Sciences, and a pipeline...
-
Uncategorized2 months ago
#AACR26 preview: Revolution Medicines, the RAS bonanza and China ADC standouts
#AACR26 preview: Revolution Medicines, the RAS bonanza and China ADC standouts
-
Uncategorized2 months ago
Trevi raises $150M; Spain and Boston set up biotech fund
Plus, news about UK clinical studies and Kura Oncology: Trevi Therapeutics to sell $150M in shares: The biotech plans to float more than 11.5 million shares...
-
Uncategorized2 months agoLilly’s obesity pill off to a strong start; OpenAI debuts new drug discovery tool
Some 1,390 Foundayo prescriptions were written in two days, according to analysts. Elsewhere, multiple biotechs are using OpenAI’s “GPT-Rosalind” and Janux debuted a “double-masked” T cell...
-
Uncategorized2 months agoSTAT+: FDA eyes expanding testosterone therapy for libido
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hellooooo, friends. Psychedelics and testosterone...
